封面
市场调查报告书
商品编码
1535659

妇科器材市场 - 按产品、最终用途 - 全球预测

Gynecological Devices Market - By Product, End-use - Global Forecast 2024-2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 190 Pages | 商品交期: 2-3个工作天内

价格
简介目录

由于妇科疾病和疾病的盛行率不断上升,2024 年至 2032 年间,妇科器材市场规模预计将达到 8.1% 的复合年增长率。子宫内膜异位症、多囊性卵巢症候群 (PCOS) 和子宫颈癌等疾病变得越来越常见,进一步推动了对诊断和治疗设备的更高需求。据报道,每 10 名女性中就有 1 名患有多囊性卵巢症候群。

技术进步,例如微创手术和复杂成像技术的发展,也促进了市场的成长。健康倡议和教育计划强调定期妇科检查和早期发现以寻求医疗护理和使用先进妇科设备的重要性。数位医疗技术和远距医疗的日益普及也扩大了妇科护理的范围,进一步推动了产品需求。

妇科器械产业分为产品、最终用途和地区。

从产品来看,诊断影像系统领域的市场规模预计将在 2032 年之前持续成长,因为它在妇科疾病的早期检测和精确诊断中发挥关键作用。超音波、磁振造影 (MRI) 和电脑断层扫描 (CT) 等先进影像技术可以实现生殖器官的详细可视化,有助于准确评估卵巢囊肿、子宫肌瘤和癌症等疾病。

就最终用途而言,预计到 2032 年,门诊手术中心领域的妇科器械行业将取得显着增长。门诊手术中心 (ASC) 进一步专注于提供当日手术护理,包括微创妇科手术,以减少住院需求并降低整体医疗费用。

由于医疗基础设施投资的增加和医疗服务的扩展,到 2032 年,亚太地区妇科设备市场规模将大幅成长。该地区的政府和私人实体正在加强其医疗保健设施,特别是在印度和中国等新兴经济体,以改善获得先进妇科护理的机会。可支配收入的增加和人们对医疗保健意识的增强也导致对专业妇科治疗和设备的需求增加,从而促进了区域市场的成长。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 妇科疾病盛行率上升
      • 加强常规检查宣传力度
      • 引进技术先进的产品
    • 产业陷阱与挑战
      • 替代疗法的采用率增加
  • 成长潜力分析
  • 报销场景
  • 监管环境
  • 技术景观
    • 核心技术
    • 邻近技术
  • 未来市场趋势
  • 波特的分析
  • PESTEL分析

第 4 章:竞争格局

  • 介绍
  • 公司市占率分析
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章:市场估计与预测:按产品分类,2021 - 2032 年

  • 主要趋势
  • 手术器械
    • 妇科内视镜设备
      • 子宫腔镜
      • 阴道镜
      • 电切镜
      • 腹腔镜
      • 内视镜成像系统
    • 子宫内膜移除装置
      • 水热消融装置
      • 射频消融设备
      • 球囊消融装置
      • 其他子宫内膜移除装置
    • 流体管理系统
    • 女性绝育/避孕器具
      • 永久节育
      • 子宫内避孕器 (IUD)
      • 阴道内环
      • 皮下植入避孕药
  • 手持式仪器
    • 阴道窥器
    • 特纳库鲁姆
    • 刮匙
    • 套管针
    • 切片钳
    • 其他手持式仪器
  • 诊断影像系统

第 6 章:市场估计与预测:按最终用途分类,2021 - 2032 年

  • 主要趋势
  • 医院和诊所
  • 门诊手术中心
  • 诊断中心
  • 其他最终用户

第 7 章:市场估计与预测:按地区,2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第 8 章:公司简介

  • Abbott Laboratories
  • Bayer AG
  • Boston Scientific Corporation
  • CooperSurgical, Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • Hologic, Inc.
  • Intuitive Surgical, Inc.
  • Johnson & Johnson (Ethicon, Inc.)
  • Karl Storz SE & Co. KG
  • Medtronic plc
  • Olympus Corporation
  • Richard Wolf GmbH
  • Smith & Nephew plc
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
简介目录
Product Code: 9822

Gynecological devices market size is poised to witness 8.1% CAGR between 2024 and 2032 driven by the increasing prevalence of gynecological disorders and diseases. Conditions, such as endometriosis, polycystic ovary syndrome (PCOS), and cervical cancer are becoming more common, further prompting the higher demand for diagnostic and therapeutic devices. As per reports, 1 in every 10 women suffer from PCOS.

Technological advancements, such as the development of minimally invasive procedures and sophisticated imaging techniques, are also contributing to the market growth. Health initiatives and educational programs are emphasizing the importance of regular gynecological check-ups and early detection for seeking medical attention and utilizing advanced gynecological devices. The rising adoption of digital health technologies and telemedicine has also expanded access to gynecological care, further boosting the product demand.

The gynecological devices industry is classified into product, end-use, and region.

Based on product, the market size from the diagnostic imaging systems segment is anticipated to witness growth through 2032 due to its critical role in the early detection and precise diagnosis of gynecological conditions. Advanced imaging technologies, such as ultrasound, magnetic resonance imaging (MRI), and computed tomography (CT) are enabling the detailed visualization of the reproductive organs for facilitating accurate assessments of disorders like ovarian cysts, fibroids, and cancers.

In terms of end-use, the gynecological devices industry from the ambulatory surgical centers segment is predicted to record notable gains up to 2032. This is owing to the rising preference for outpatient surgical procedures to offer convenience and cost-effectiveness. Ambulatory surgical centers (ASCs) further specialize in providing same-day surgical care, including minimally invasive gynecological procedures to reduce the need for hospital admissions and lower the overall healthcare costs.

Asia Pacific gynecological devices market size will grow significantly through 2032 attributed to the increasing investments in healthcare infrastructure and the expansion of healthcare services. Governments and private entities in the region are enhancing their healthcare facilities, particularly in emerging economies like India and China to improve access to advanced gynecological care. The rising disposable incomes and the growing healthcare awareness among the population are also leading to higher demand for specialized gynecological treatments and devices, adding to the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of gynecological disorders
      • 3.2.1.2 Increase in initiatives promoting routine checkup
      • 3.2.1.3 Introduction of technically advanced products
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Increase in adoption of alternate therapies
  • 3.3 Growth potential analysis
  • 3.4 Reimbursement scenario
  • 3.5 Regulatory landscape
  • 3.6 Technological landscape
    • 3.6.1 Core technologies
    • 3.6.2 Adjacent technologies
  • 3.7 Future market trends
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Surgical devices
    • 5.2.1 Gynecological endoscopy devices
      • 5.2.1.1 Hysteroscope
      • 5.2.1.2 Colposcope
      • 5.2.1.3 Resectoscope
      • 5.2.1.4 Laparoscope
      • 5.2.1.5 Endoscope imaging systems
    • 5.2.2 Endometrial ablation devices
      • 5.2.2.1 Hydrothermal ablation devices
      • 5.2.2.2 Radiofrequency ablation devices
      • 5.2.2.3 Balloon ablation devices
      • 5.2.2.4 Other endometrial ablation devices
    • 5.2.3 Fluid management systems
    • 5.2.4 Female sterilization/contraceptive devices
      • 5.2.4.1 Permanent birth control
      • 5.2.4.2 Intra uterine devices (IUD)
      • 5.2.4.3 Intravaginal rings
      • 5.2.4.4 Subdermal contraceptive implants
  • 5.3 Handheld instruments
    • 5.3.1 Vaginal speculum
    • 5.3.2 Tenaculum
    • 5.3.3 Curettes
    • 5.3.4 Trocars
    • 5.3.5 Biopsy forceps
    • 5.3.6 Other handheld instruments
  • 5.4 Diagnostic imaging systems

Chapter 6 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Hospital and clinics
  • 6.3 Ambulatory surgery centers
  • 6.4 Diagnostic centers
  • 6.5 Other end-users

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Netherlands
    • 7.3.7 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
    • 7.4.6 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Rest of Latin America
  • 7.6 Middle East and Africa
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE
    • 7.6.4 Rest of Middle East and Africa

Chapter 8 Company Profiles

  • 8.1 Abbott Laboratories
  • 8.2 Bayer AG
  • 8.3 Boston Scientific Corporation
  • 8.4 CooperSurgical, Inc.
  • 8.5 Fresenius Medical Care AG & Co. KGaA
  • 8.6 Hologic, Inc.
  • 8.7 Intuitive Surgical, Inc.
  • 8.8 Johnson & Johnson (Ethicon, Inc.)
  • 8.9 Karl Storz SE & Co. KG
  • 8.10 Medtronic plc
  • 8.11 Olympus Corporation
  • 8.12 Richard Wolf GmbH
  • 8.13 Smith & Nephew plc
  • 8.14 Stryker Corporation
  • 8.15 Zimmer Biomet Holdings, Inc.